Company intelligence / Profile preview

Silver Delaware Investment

St Helier, Jersey

Ownership: Private
Development stage: Other

Overview

Silver Delaware Investment Limited is an investment vehicle primarily known for its significant role as a major shareholder in Sosei Group Corporation (now Sosei Heptares). The entity is an affiliate of SoftBank Group Corp. and has been instrumental in providing capital and strategic backing to support the growth of Sosei's GPCR-focused drug discovery platform. While not a drug developer itself, its activities are central to the financing and corporate structuring of leading Japanese biopharmaceutical enterprises. The company functions as a holding entity to manage equity stakes in the life sciences sector.

Industry: Investors

Beyond the preview

Go deeper on Silver Delaware Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silver Delaware Investment.

Explore the full profile